Modeling deposition of inhaled particles

Aerosols Handbook: Measurement, Dosimetry, and Health Effects, Second Edition

Volumn , Issue , 2012, Pages 83-127

  Isaacs, Kristin K ^a   Rosati, Jacky A ^a   Martonen, Ted B ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b Cyberlung   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROSOLS; DRUG DELIVERY; DRUG DOSAGE; HEALTH RISKS;

AEROSOL DEPOSITION; CURRENT DEPOSITION; DEPOSITION MODELING; ENVIRONMENTAL AEROSOLS; EXPERIMENTAL METHODS; INHALED PARTICLES; LUNG DEPOSITIONS; MODEL PREDICTION;

DEPOSITION;

EID: 85015268084     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b12668     Document Type: Chapter

References (311)

1. Pedley, T. J. and Kamm, R. D., Dynamics of gas flow and pressure-flow relationships, The Lung: Scientific Foundations, Vol. I, Crystal, R. G., West, J. B., and Barnes, P. J., Eds., Raven Press, New York, 1991.
2. Martonen, T. B. and Yang, Y., Deposition mechanics of pharmaceutical particles in human airways, Inhalation Aerosols: Physical and Biological Basis for Therapy, Hickey, A. J., Ed., Marcel Dekker, Inc., New York, 1996.
3. White, F. M., Viscous Fluid Flow, McGraw-Hill, New York, 1991.
4. Chang, H. K. and El Masry, O. A., A model study of flow dynamics in human central airways. Part I: Axial velocity profiles, Respir. Physiol., 49, 75, 1982.
5. Isabey, D. and Chang, H. K., A model study of flow dynamics in human central airways. Part II: Secondary flow velocities, Respir. Physiol., 49, 97, 1982.
6. Schroter, R. C. and Sudlow, M. F., Flow patterns in the human bronchial airways, Respir. Physiol., 7, 341, 1969.
7. Martonen, T. B., Mathematical model for the selective deposition of inhaled pharmaceuticals, J. Pharm. Sci., 82, 1191, 1993.
8. Martonen, T. B., Surrogate experimental models for studying particle deposition in the human respiratory tract: An overview, Aerosols: Research, Risk Assessment, and Control Strategies, Lee, S. D., Schneider, T., Grant, L. D., and Verkerk, P. J., Eds., Lewis Publishers, Chelsea, MI, 1986.
9. Zhang, Z. and Martonen, T. B., Deposition of ultrafine aerosols in human tracheobronchial airways, Inhal. Toxicol., 9, 99, 1997.
10. Martonen, T. B. Yang, Y., and Xue, Z. Q., Effects of carinal ridge shapes on lung airstreams, Aerosol Sci. Technol., 21, 119, 1994.
11. Martonen, T. B., Yang, Y., Xue, Z. Q., and Zhang, Z., Motion of air within the human tracheobronchial tree, Part. Sci. Technol., 12, 175, 1994.
12. Martonen, T. B., Yang, Y., and Xue, Z. Q., Influences of cartilaginous rings on tracheobronchial fluid dynamics, Inhal. Toxicol., 6, 185, 1994.
13. Martonen, T. B., Guan, X., and Schrek, R. M., Fluid dynamics in airway bifurcations: I. Primary flows, Inhal. Toxicol., 13, 261, 2001.
14. Martonen, T. B., Guan, X., and Schrek, R. M., Fluid dynamics in airway bifurcations: II. Secondary currents, Inhal. Toxicol., 13, 281, 2001.
15. Martonen, T. B., Guan, X., and Schrek, R. M., Fluid dynamics in airway bifurcations: III. Localized flow conditions, Inhal. Toxicol., 13, 291, 2001.
16. Kimbell, J. S., Gross, E. A., Joyner, D. R., Godo, N. M., and Morgan, K. T., Application of computational fluid dynamics to regional dosimetry of inhaled chemicals in the upper respiratory tract of the rat, Toxicol. Appl. Pharmacol., 121, 253, 1993.
17. Yu, G., Zhang G., and Lessman, R., Fluid flow and particle diffusion in the human upper respiratory system, Aerosol Sci. Technol., 28, 146, 1998.
18. Martonen, T. B., Zhang, Z., Yue, G., and Musante, C. J.,3-D particle transport within the human upper respiratory tract, J. Aerosol Sci., 33, 1095, 2002.
19. Stahlhofen, W., Rudolph, G., and James, A. C., Intercomparison of experimental regional aerosol deposition data, J. Aerosol Med., 2, 285, 1989.
20. Rudolf, G., Gebhart, J., Heyder, J., Schiller, C. F., and Stahlhofen, W., An empirical-formula describing aerosol deposition in man for any particle size, J. Aerosol Sci., 17, 350, 1986.
21. Commission on Radiological Protection, ICRP Publication 66, Human respiratory tract model for radiological protection, Ann. ICRP, 24, 1-3, 1994.
22. Rudolf, G., Kobrich, R., and Stahlhofen, W., Modeling and algebraic formulation of regional aerosol deposition in man, J. Aerosol Sci., 21, S403, 1990.
23. Rudolf, G., Gebhart, J., Heyder, J., Scheuch, G., and Stahlhofen, W., Modeling the deposition of aerosol-particles in the human respiratory-tract, J. Aerosol Sci., 14, 188, 1983.
24. Rudolph, G., Gebhardt, J., Heyder, J., Schiller, C. F., and Stahlhofen, W., Mass deposition from inspired polydisperse aerosols, Ann. Occup. Hyg., 32, 919, 1988.
25. Gonda, I., A semi-empirical model of aerosol deposition in the human respiratory tract for mouth inhalation, J. Pharm. Pharmacol., 33, 692, 1981.
26. Chan, T. L. and Lippmann, M., Experimental measurements and empirical modelling of the regional deposition of inhaled particles in humans, Am. Ind. Hyg. Assoc. J., 41, 399, 1980.
27. Cohen, B. S. and Asgharian, B., Deposition of ultrafine particles in the upper airways: An empirical analysis, J. Aerosol Sci., 21, 789, 1990.
28. Asgharian, B., Wood, R., and Schlesinger, R. B., Empirical modeling of particle deposition in the alveolar region of the lungs: A basis for interspecies extrapolation, Fund. Appl. Toxicol., 27, 232, 1995.
29. Kim, C. S. and Hu, S. C., Total respiratory tract deposition of fine micrometer-sized particles in healthy adults: Empirical equations for sex and breathing pattern, J. Appl. Physiol., 101(2), 401-412, 2006.
30. Carpenter, R. L. and Kimmel, E. C., Aerosol deposition modeling using ACSL, Drug Chem. Toxicol., 22, 73, 1999.
31. Zhang, Z. and Martonen, T. B., Comparison of theoretical and experimental particle diffusion data within human airway casts, Cell Biochem. Biophys., 27, 97, 1995.
32. Martonen, T. B., Analytical model of hygroscopic particle behavior in human airways, Bull. Math. Biol., 44, 425, 1982.
33. Gradón, L. and Orlicki, D., Deposition of inhaled aerosol particles in a generation of the tracheobronchial tree, J. Aerosol Sci., 21, 3, 1990.
34. Yu, C. P., A two-component theory of aerosol deposition in lung airways, Bull. Math. Biol., 40, 693, 1978.
35. Yu, C. P. and Diu, C. K., A comparative study of aerosol deposition in different lung models, Am. Ind. Hyg. Assoc. J., 43, 54, 1982.
36. Egan, M. J. and Nixon, W., A model of aerosol deposition in the lung for use in inhalation dose assessments, Radiat. Prot. Dosim., 11, 5, 1985.
37. Anjilvel, S. and Asgharian, B., A multiple-path model of particle deposition in the rat lung, Fund. Appl. Toxicol., 28, 41, 1995.
38. Asgharian, B., Menache, M. G., and Miller, F. J., Modeling age-related particle deposition in humans, J. Aerosol Med., 17, 213, 2004.
39. Phalen, R. F., Oldham, M. J., and Mautz, W. J., Aerosol deposition in the nose as a function of body size, Health Phys., 57, 299, 1989.
40. Phalen, R. F. and Oldham, M. J., Methods for modeling particle deposition as a function of age, Respir. Physiol., 128, 119, 2001.
41. Choi J. I. and Kim C. S., Mathematical analysis of particle deposition in human lungs: An improved single path transport model. Inhal. Toxicol., 19, 925, 2007.
42. Koblinger, L. and Hofmann, W., Analysis of human lung morphometric data for stochastic aerosol deposition calculations, Phys. Med. Biol., 30, 541, 1985.
43. Koblinger, L. and Hofmann, W., Monte Carlo modeling of aerosol deposition in human lungs: Part I: Simulation of particle transport in a stochastic lung structure, J. Aerosol Sci., 21, 661, 1990.
44. Asgharian, B., Price, O. T., and Hofmann, W., Prediction of particle deposition in the human lung using realistic models of lung ventilation, J. Aerosol Sci., 37, 1209, 2006.
45. Sturm, R. and Hofmann, W., 3D-visualization of particle deposition patterns in the human lung generated by Monte Carlo modeling: Methodology and applications, Comput. Biol. Med., 35, 41, 2005.
46. Koblinger, L. and Hofmann, W., Stochastic morphological model of the rat lung, Anat. Rec., 221, 533, 1988.
47. Hofmann, W., Koblinger, L., and Martonen, T. B., Structural differences between human and rat lungs: Implications for Monte Carlo modeling of aerosol deposition, Health Phys., 57, 41, 1989.
48. Hofmann, W., Asgharian, B., Bergmann, R., Anjilvel, S., and Miller, F. J., The effect of heterogeneity of lung structure on particle deposition in the rat lung, Toxicol. Sci., 53, 430, 2000.
49. Hofmann, W., Koblinger, L., and Mohamed, A., Incorporation of biological variability into lung dosimetry by stochastic modeling techniques, Environ. Int., 22, S995, 1996.
50. Hofmann, W., Morawska, L., and Bergmann, R., Environmental tobacco smoke deposition in the human respiratory tract: Differences between experimental and theoretical approaches, J. Aerosol Med., 14, 317, 2001.
51. Alfoldy, B., Giechaskiel, B., Hofmann, W., and Drossinos, Y., Size-distribution dependent lung deposition of diesel exhaust particles, J. Aerosol Sci., 40, 652, 2009.
52. Hofmann, W. and Koblinger, L., Monte Carlo modeling of aerosol deposition in human lungs: Part II: Deposition fractions and their sensitivity to parameter variations, J. Aerosol Sci., 21, 675, 1990.
53. Comer, J. K., Kleinstreuer, C., and Zhang, Z., Flow structures and particle deposition patterns in double-bifurcation airway models. Part 2. Aerosol transport and deposition, J. Fluid Mech., 435, 55, 2001.
54. Martonen, T. B. and Guan, X., Effects of tumors on inhaled pharmacologic drugs. I. Flow patterns, Cell Biochem. Biophys., 35, 233, 2001.
55. Martonen, T. B. and Guan, X., Effects of tumors on inhaled pharmacologic drugs. II. Particle motion, Cell Biochem. Biophys., 35, 245, 2001.
56. Zhang, Z., Kleinstreuer, C., and Kim, C. S., Cyclic micron-sized particle inhalation and deposition in a triple bifurcation lung airway model, J. Aerosol Sci., 33, 257, 2001.
57. Zhang, Z., Kleinstreuer, C., and Kim, C. S., Effects of curved inlet tubes on airflow and particle deposition in bifurcating lung models, J. Biomech., 34, 659, 2001.
58. Zhang, Z., Kleinstreuer, C., and Kim, C. S., Flow structure and particle transport in a triple bifurcation airway model, J. Fluids Eng., 123, 320, 2001.
59. Zhang, Z., Kleinstreuer, C., and Kim, C. S., Airflow and nanoparticle deposition in a 16-generation tracheobronchial airway model, Ann. Biomed. Eng., 36, 2095, 2008.
60. Comer, J. K., Kleinstreuer, C., and Zhang, Z., Flow structures and particle deposition patterns in double-bifurcation airway models. Part 1. Air flow fields, J. Fluid Mech., 435, 25, 2001.
61. Longest, P. W. and Oldham, M. J., Mutual enhancements of CFD modeling and experimental data: A case study of 1-mum particle deposition in a branching airway model, Inhal. Toxicol., 18, 761, 2006.
62. Longest, P. W., Vinchurkar, S., and Martonen, T., Transport and deposition of respiratory aerosols in models of childhood asthma, J. Aerosol Sci., 37, 1234, 2006.
63. Isaacs, K. K., Schlesinger, R. B., and Martonen, T. B., Three-dimensional computational fluid dynamics simulations of particle deposition in the tracheobronchial tree, J. Aerosol Med., 19, 344, 2006.
64. Zhang, Z., Kleinstreuer, C., Kim, C. S., and Hickey, A. J., Aerosol transport and deposition in a triple bifurcation bronchial airway model with local tumors, Inhal. Toxicol., 14, 1111, 2002.
65. Choi, L. T., Tu, J. Y., Li, H. F., and Thien, F., Flow and particle deposition patterns in a realistic human double bifurcation airway model, Inhal. Toxicol., 19, 117, 2007.
66. Inthavong, K., Choi, L. T., Tu, J., Ding, S., and Thien, F., Micron particle deposition in a tracheobronchial airway model under different breathing conditions, Med. Eng. Phys., 32, 1198-1212, 2010.
67. Ma, B. and Lutchen, K., CFD simulation of aerosol deposition in an anatomically based human large-medium airway model, Ann. Biomed. Eng., 37, 271, 2009.
68. Gemci, T., Ponyavin, V., Chen, Y., Chen, H., and Collins, R., Computational model of airflow in upper 17 generations of human respiratory tract, J. Biomech., 41, 2047, 2008.
69. Inthavong, K., Tu, J. Y., Ye, Y., Ding, S. L., Subic, A., and Thien, F., Effects of airway obstruction induced by asthma attack on particle deposition, J. Aerosol Sci., 41, 587, 2010.
70. Xi, J. X. and Longest, P. W., Transport and deposition of micro-aerosols in realistic and simplified models of the oral airway, Ann. Biomed. Eng., 35, 560, 2007.
71. Zhang, Z., Kleinstreuer, C., and Kim, C. S., Micro-particle transport and deposition in a human oral airway model, J. Aerosol Sci., 33, 1635, 2002.
72. Xi, J. X. and Longest, P. W., Effects of oral airway geometry characteristics on the diffusional deposition of inhaled nanoparticles, J. Biomech. Eng., 130, 011008, 2008.
73. Inthavong, K., Wen, H., Tian, Z. F., and Tu, J. Y., Numerical study of fibre deposition in a human nasal cavity, J. Aerosol Sci., 39, 253, 2008.
74. Tian, Z. F., Inthavong, K., and Tu, J. Y., Deposition of inhaled wood dust in the nasal cavity, Inhal. Toxicol., 19, 1155, 2007.
75. Shi, H., Kleinstreuer, C., and Zhang, Z., Laminar airflow and nanoparticle or vapor deposition in a human nasal cavity model, J. Biomech. Eng., 128, 697, 2006.
76. Schroeter, J. D., Kimbell, J. S., and Asgharian, B., Analysis of particle deposition in the turbinate and olfactory regions using a human nasal computational fluid dynamics model, J. Aerosol Med., 19, 301, 2006.
77. Wang, S. M., Inthavong, K., Wen, J., Tu, J. Y., and Xue, C. L., Comparison of micron-and nanoparticle deposition patterns in a realistic human nasal cavity, Respir. Physiol. Neurobiol., 166, 142, 2009.
78. Heenan, A. F., Matida, E., Pollard, A., and Finlay, W. H., Experimental measurements and computational modeling of the flow field in an idealized human oropharynx, Exp. Fluids, 35, 70, 2003.
79. Hofmann, W., Modeling techniques for inhaled particle deposition: The state of the art, J. Aerosol Med., 9, 369, 1996.
80. Zhang, Z. and Kleinstreuer, C., Transient airflow structures and particle transport in a sequentially branching lung airway model, Phys. Fluids, 14, 862, 2002.
81. Martonen, T. B. and Schroeter, J. D., Risk assessment dosimetry model for inhaled particulate matter: I. Human subjects, Toxicol. Lett., 138, 119, 2003.
82. Asgharian, B. and Price, O. T., Deposition of ultrafine (nano) particles in the human lung, Inhal. Toxicol., 19, 1045, 2007.
83. Geiser, M. and Kreyling, W. G., Deposition and biokinetics of inhaled nanoparticles, Part. Fibre Toxicol., 7, 2, 2010.
84. Sung, J. C., Pulliam, B. L., and Edwards, D. A., Nanoparticles for drug delivery to the lungs, Trends Biotechnol., 25, 563, 2007.
85. Sung, J. C., Padilla, D. J., Garcia-Contreras, L., Verberkmoes, J. L., Durbin, D., Peloquin, C. A., Elbert, K. J., Hickey, A. J., and Edwards, D. A., Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery, Pharm. Res., 26, 1847, 2009.
86. Brown, J. S., Particle inhalability at low wind speeds, Inhal. Toxicol., 17, 831, 2005.
87. Menache, M. G., Miller, F. J., and Raabe, O. G., Particle inhalability curves for humans and small laboratory animals, Ann. Occup. Hyg., 39, 317, 1995.
88. Millage, K. K., Bergman, J., Asgharian, B., and McClellan, G., A review of inhalability fraction models: Discussion and recommendations, Inhal. Toxicol., 22, 151, 2010.
89. Se, C. M. K., Inthavong, K., and Tu, J. Y., Inhalability of micron particles through the nose and mouth, Inhal. Toxicol., 22, 287, 2010.
90. Anthony, T. R., Flynn, M. R., and Eisner, A., Evaluation of facial features on particle inhalation, Ann. Occup. Hyg., 49, 179, 2005.
91. Weibel, E. R., Morphometry of the Human Lung, Academic Press, New York, 1963.
92. Weibel, E. R., Design of airways and blood vessels as branching trees, The Lung: Scientific Foundations, Vol. I, Crystal, R. G., West, J. B., Barnes, P. J., Cherniak, N. S., and Weibel E. R., Eds., Raven Press, New York, 1991.
93. Horsfield, K., Pulmonary airways and blood vessels considered as confluent trees, The Lung: Scientific Foundations, Vol. I, Crystal, R. G., West, J. B., Barnes, P. J., Cherniak, N. S., and Weibel E. R., Eds., Raven Press, New York, 1991.
94. Horsfield, K. and Cumming, G., Angles of branching and diameters of branches in the human bronchial tree, Bull. Math. Biophys., 29, 245, 1967.
95. Horsfield, K. and Cumming, G., Morphology of the bronchial tree in man, J. Appl. Physiol., 24, 373, 1968.
96. Soong, T. T., Nicolaides, P., Yu, C. P., and Soong, S. C., A statistical description of the human tracheobronchial tree geometry, Respir. Physiol., 37, 161, 1979.
97. Jesseph, J. E. and Merendino, K. A., The dimensional interrelationships of the major components of the human tracheobronchial tree, Surg. Gynecol. Obstet., 105, 210, 1957.
98. Parker, H., Horsfield, K., and Cumming, G., Morphology of the distal airways in the human lung, J. Appl. Physiol., 31, 386, 1971.
99. Horsfield, K., Dart, G., Olson, D. E., Filley, G. F., and Cumming, G., Models of the human tracheobronchial tree, J. Appl. Physiol., 31, 207, 1971.
100. Kitaoka, H., Takaki, R., and Suki, B., A three-dimensional model of the human airway tree, J. Appl. Physiol., 87, 2207, 1999.
101. Martonen, T. B., Schroeter, J. D., and Fleming, J. S., 3D in silico modeling of the human respiratory system for inhaled drug delivery and imaging analysis, J. Pharm. Sci., 96, 603, 2007.
102. Martonen, T. B., Schroeter, J. D., Hwang, D., Fleming, J. S., and Conway, J. H., Human lung morphology models for particle deposition studies, Inhal. Toxicol., 12(Suppl. 4), 109, 2000.
103. Montesantos, S., Fleming, J. S., and Tossici-Bolt, L., A spatial model of the human airway tree: The Hybrid Conceptual Model, J. Aerosol Med. Pulm. Drug Deliv., 23, 59, 2010.
104. Spencer, R. M., Schroeter, J. D., and Martonen, T. B., Computer simulations of lung airway structures using data-driven surface modeling techniques, Comput. Biol. Med., 31, 499, 2001.
105. Inthavong, K., Wen, J., Tu, J. Y., and Tian, Z. F., From Ct scans to Cfd modelling-Fluid and heat transfer in a realistic human nasal cavity, Eng. Appl. Comput. Fluid, 3, 321, 2009.
106. Martonen, T. B., Smyth, H. D., Isaacs, K. K., and Burton, R. T., Issues in drug delivery: Concepts and practice, Respir. Care, 50, 1228, 2005.
107. Rosati, J., Burton, R., McCauley, R., and McGregor, G., Three dimensional modeling of the human respiratory system, presented at 29th Annual Meeting of the American Association for Aerosol Research, Portland, Oregon, October 25-29, 2010, http://aaarabstracts.com/2010/viewabstract.php?paper-859.
108. National Institutes of Health, National Library of Medicine Visible Human Project. Available at: http://www.nlm.nih.gov/research/visible/visible_human.html
109. Yeh, H. C. and Schum, G. M., Models of human lung airways and their application to inhaled particle deposition, Bull. Math Biol., 42, 461, 1980.
110. Musante, C. and Martonen, T. B., Computational fluid dynamics in human lungs I: Effects of natural airway features, Medical Applications of Computer Modeling: The Respiratory System, Martonen, T. B., Ed., WIT Press, Boston, MA, 2001.
111. Martonen, T. B., Zhang, Z., Yang, Y., and Bottei, G., Airway surface irregularities promote particle diffusion in the human lung, Radiat. Prot. Dosim., 59, 5, 1995.
112. Balásházy, I. and Hofmann, W., Quantification of local deposition patterns of inhaled radon decay products in human bronchial airway bifurcations, Health Phys., 78, 147, 2000.
113. Niinimaa, V., Cole, P., Mintz, S., and Shephard, R. J., The switching point from nasal to oronasal breathing, Respir. Phys., 42, 61, 1980.
114. Niinimaa, V., Cole, P., Mintz, S., and Shephard, R. J., Oronasal distribution of respiratory airflow, Respir. Phys., 43, 69, 1981.
115. James, D. S., Lambert, W. E., Mermier, C. M., Stidley, C. A., Chick, T. W., and Samet, J. M., Oronasal distribution of ventilation at different ages, Arch. Environ. Health, 52, 118, 1997.
116. Everard, M. L., Hardy, J. G., and Milner, A. D., Comparison of nebulised aerosol deposition in the lungs of healthy adults following oral and nasal inhalation, Thorax, 48, 1045, 1993.
117. Brain, J. D. and Sweeney, T. D., Effects of ventilatory patterns and pre-existing disease on deposition of inhaled particles in animals, Ch. 15, Extrapolation of Dosimetric Relationships for Inhaled Particles and Gases, Crapo, J. D., Miller, F. J., Smolko, E. D., Graham, J. A., and Hayes, A. W., Eds., Academic Press, Inc., New York, 1989.
118. Lennon, S., Shang, S., Lessmann, R., and Webster, S., Experiments on particle deposition in the human upper respiratory system, Aerosol Sci. Technol., 28, 464, 1998.
119. Becquemin, M. H., Swift, D. L., Bouchikhi, A., Roy, M., and Teillac, A., Particle deposition and resistance in the noses of adults and children, Eur. Respir. J., 4, 694, 1991.
120. Swift, D. L. and Strong, J. C., Nasal deposition of ultrafine 218Po aerosols in human subjects, J. Aerosol Sci., 27, 1125, 1996.
121. Schwab, J. A. and Zenkel, M., Filtration of particles in the human nose, Laryngoscope, 108, 120, 1998.
122. Morawska, L., Barron., W., and Hitchins, J., Experimental deposition of environmental tobacco smoke submicrometer particulate matter in the human respiratory tract, Am. Ind. Hyg. Assoc. J., 60, 334, 1999.
123. Anderson, I., Lundquist, G. R., Proctor, D. F., and Swift, D. L., Human response to controlled levels of inert dust, Am. Rev. Respir. Dis., 119, 619, 1979.
124. Cheng, K., Cheng, Y., Yeh, H., Guilmette, R. A., Simpson, S. Q., Yang, Y., and Swift, D. L., In vivo measurements of nasal airway dimensions and ultrafine aerosol deposition in the human nasal and oral airways, J. Aerosol Sci., 27, 785, 1996.
125. Kesavan, J., Bascom, R., Laube, B., and Swift, D. L., The relationship between particle deposition in the anterior nasal passage and nasal passage characteristics, J. Aerosol Med., 13, 17, 2000.
126. Brand, P., Friemel, I., Meyer, T., Schulz, H., Heyder, J., and Haubinger, K., Total deposition of therapeutic particles during spontaneous and controlled inhalations, J. Pharm. Sci., 89, 724, 2000.
127. Heyder, J., Gebhart, J., Stahlhofen, W., and Stuck, B., Biological variability of particle deposition in the human respiratory tract during controlled and spontaneous mouth-breathing, Ann. Occup. Hyg., 26, 137, 1982.
128. Bennett, W. D. and Smaldone, G. C., Human variation in the peripheral air-space deposition of inhaled particles, J. Appl. Physiol., 62, 1603, 1987.
129. Schiller-Scotland, C. F., Hlawa, R., and Gebhart, J., Experimental data for total deposition in the respiratory tract of children, Toxicol. Lett., 72, 137, 1994.
130. Brown, J. S., Zeman, K. L., and Bennett, W. D., Ultrafine particle deposition and clearance in the healthy and obstructed lung, Am. J. Respir. Crit. Care Med., 166, 1240, 2002.
131. Bennett, W. D., Messina, M., and Smaldone, G. C., Effect of exercise on deposition and subsequent retention of inhaled particles, J. Appl. Physiol., 59, 1046, 1985.
132. Messina, M. A. and Smaldone, G. C., Evaluation of quantitative aerosol techniques for use in bronchoprovocation studies, J. Allergy Clin. Immunol., 75, 252, 1985.
133. Stahlhofen, W., Gebhart, J., and Heyder, J., Experimental determination of the regional deposition of aerosol particles in the human respiratory tract, Am. Ind. Hyg. Assoc. J., 41, 385, 1980.
134. Heyder, J., Armbruster, L., Gebhart, J., Grein, E., and Stahlhofen, W., Total deposition of aerosol particles in the human respiratory tract for nose and mouth breathing, J. Aerosol Sci., 6, 311, 1975.
135. Svartengren, M., Svartengren, K., Aghaie, F., Philipson, K., and Camner, P., Lung deposition and extremely slow inhalations of particles. Limited effect of induced airway obstruction, Exp. Lung Res., 25, 353, 1999.
136. Keck, T., Leiacker, R., Heinrich, A., Khunemann, S., and Rettinger, G., Humidity and temperature profile in the nasal cavity, Rhinology, 38, 167, 2000.
137. Ingelstedt, S., Studies on the conditioning of air in the respiratory tract, Acta Otoalaryngol., 131, 1, 1956.
138. Cole, P., Recordings of respiratory air temperature, J. Laryngol. Otol., 68, 295, 1954.
139. Perwitzschky, R., Die temperatur and feuchtigkeitsverhaltnisse der atemluft in den luftwegen.1, Mitt. Arch. Ohren Nasen Kehlkopfh, 117, 1, 1928.
140. Verzar, F., Keith, T., and Parchet, V., Temperatur and feuchtigkeit der lugt in den atemwegen, Pflugers Arch. Ges. Physiol., 257, 400, 1953.
141. Herlitzka, A., Sur la temperature tracheale de l’air inspire et expire, Arch. Int. Physiol., 18, 587, 1921.
142. Dery, R., Pelletier, J., Jaques, H., Clavet, M., and Houde, J. J., Humidity in anaesthesiology. III. Heat and moisture patterns in the respiratory tract during anaesthesia with the semi-closed system, Can. Anaesth. Soc. J., 14, 287, 1967.
143. Dery, R., The evolution of heat and moisture in the respiratory tract during anaesthesia with a non-rebreathing system, Can. Anaesth. Soc. J., 20, 296, 1973.
144. McFadden, E. R., Pichurko, B. M., Bowman, F. H., Ingenito, E., Burns, S., Dowling, N., and Solway, J., Thermal mapping of the airways in humans, J. Appl. Physiol., 58, 564, 1985.
145. McRae, R. D. R., Jones, A. S., Young, P., and Hamilton, J., Resistance, humidity and temperature of the tracheal airway, Clin. Otolaryngol., 20, 355, 1995.
146. Martonen, T. B., Hoffman, W., Eisner, A. D., and Ménache, M. G., The role of particle hygroscopicity in aerosol therapy and inhalation toxicology, Extrapolation of Dosimetric Relationships for Inhaled Particles and Gases, Crapo, J. D., Smolko, and E. D., Eds., Academic Press, Inc., New York, 1989.
147. Kousaka, Y., Okuyama, K. and Wang, C. S., Response of cigarette smoke particles to change in humidity, J. Chem. Eng. Jpn., 15, 75, 1982.
148. Li, W. and Hopke, P. K., Initial size distributions and hygroscopicity of indoor combustion aerosol particles, Aerosol Sci. Technol., 19, 305, 1993.
149. Hicks, J. F., Pritchard, J. N., Black, A., and Megaw, W. J., Experimental evaluation of aerosol growth in the human respiratory tract, Aerosols: Formation and Reactivity, Schikarski W., Fissan H. J., and Friedlander, S. K., Eds., Pergamon Press, Oxford, U.K., 1986, p. 243.
150. Gysel, M., Weingartner E., and Baltensperger, U., Hygroscopicity of aerosol particles at low temperatures.Theoretical and experimental hygroscopic properties of laboratory generated aerosols, Environ. Sci. Technol., 36(1), 63, 2002.
151. Tang, I. N., Munkelwitz, H. R., and Davis, J. G., Aerosol growth studies, II. Preparation and growth measurements of monodisperse salt aerosols, J. Aerosol Sci., 8, 149, 1977.
152. Tang, I. N. and Munkelwitz, H. R., Aerosol growth studies, III. Ammonium bisulfate aerosols in a moist atmosphere, J. Aerosol Sci., 8, 321, 1977.
153. Smith, G., Hiller, F. C., Mazumder, M. K., and Bone R. C., Aerodynamic size distribution of cromolyn sodium at ambient and airway humidity, Am. Rev. Respir. Dis., 121, 513, 1980.
154. Hiller, F. C., Mazumder, M. K., Wilson, J. D., and Bone R. C., Effect of low and high relative humidity on metered-dose bronchodilator solution and powder aerosols, J. Pharm. Sci., 69, 334, 1980.
155. Hiller, F. C., Mazumder, M. K., Wilson, J. D., and Bone R. C., Aerodynamic size distribution, hygroscopicity and deposition estimation of beclomethasone dipropionate aerosol, J. Pharm. Pharmacol., 32, 605, 1980.
156. Kim, C. S., Trujillo, D., and Sackner, M. A., Size aspects of metered-dose inhaler aerosols, Am. Rev. Respir. Dis., 132, 137, 1985.
157. Seemann, S., Busch B., Ferron, G. A., Silberg, A., and Heyder, J., Measurement of the hygroscopicity of pharmaceutical aerosols in situ. J. Aerosol Sci., 26, 537, 1995.
158. Peng, C., Chow, A. H., and Chan, C. K., Study of the hygroscopic properties of selected pharmaceutical aerosols using single particle levitation, Pharm. Res., 17, 1104, 2000.
159. Bell, K. A. and Ho, A. T., Growth rate measurements of hygroscopic aerosols under conditions simulating the respiratory tract, J. Aerosol Sci., 12, 247, 1981.
160. Martonen, T. B., Bell, K. A., Phalen, R. F., Wilson, A. F., and Ho, A. T., Growth rate measurements and deposition modeling of hygroscopic aerosols in human tracheobronchial models, Ann. Occup. Hyg., 26, 93, 1982.
161. Broday, D. M. and Georgopoulos, P. G, Growth and deposition of hygroscopic particulate matter in the human lungs, Aerosol Sci. Technol., 34, 144, 2001.
162. Finlay, W. H., Estimating the type of hygroscopic behavior exhibited by aqueous droplets, J. Aerosol Med., 11, 221, 1998.
163. Robinson, R. J. and Yu, C. P., Theoretical analysis of hygroscopic growth rate of mainstream and sidestream cigarette smoke particles in the human respiratory tract, Aerosol Sci. Technol., 28, 21, 1998.
164. Ferron, G. A., The size of soluble aerosol particles as a function of the humidity of the air. Application to the human respiratory tract, J. Aerosol Sci., 8, 251, 1977.
165. Oberdörster, G., Lung clearance of inhaled insoluble and soluble particles, J. Aerosol Med., 1, 289, 1988.
166. West, J. B., Pulmonary Pathophysiology, The Essentials, 5th edn., Lippincott, Williams & Wilkins, Philadelphia, PA, 1998.
167. Gehr, P., Schurch, S., Im Hof, V., and Geiser, M., Inhaled particles deposited in the airways are displaced towards the epithelium, Inhaled Particles VII, The Annals of Occupational Hygiene, Walton, W. H., Critchlow, A., and Coppock, S. M., Eds., Pergamon Press, New York, 1994.
168. West, J. B., Respiratory Physiology, The Essentials, 6th edn., Lippincott, Williams & Wilkins, Philadelphia, PA, 2000.
169. Yeates, D. B., Gerrity, T. B., and Garrard, C. S., Characteristics of tracheobronchial deposition and clearance in man, Inhaled Particles V, The Annals of Occupational Hygiene, Walton, W. H., Critchlow, A., and Coppock, S. M., Eds., Pergamon Press, New York, 1982.
170. Yeates, D. B., Gerrity, T. B., and Garrard, C. S., Particle deposition and clearance in the bronchial tree, Ann. Biomed. Eng., 9, 577, 1981.
171. Fazio, F. and Lafortuna, C., Effect of inhaled salbutamol on mucociliary clearance in patients with chronic bronchitis, Chest, 80, 827, 1981.
172. Foster, W. M., Langenback, E. G., and Bergofsky, E. H., Respiratory drugs influence mucociliary clearance in central and peripheral ciliated airways, Chest, 80, 877, 1981.
173. Foster, W. M., Langenback, E. G., and Bergofsky, E. H., Lung mucociliary function in man, Ann. Occup. Hyg., 26, 227, 1982.
174. Mortensen, J., Lange, P., Nyboe, J., and Groth, S., Lung mucociliary clearance, Eur. J. Nucl. Med., 21, 953, 1994.
175. Weiss, T., Dorrow, P., and Felix, R., Effects of a beta adrenergic drug and a secretolytic agent on regional mucociliary clearance in patients with COLD, Chest, 80, 881, 1981.
176. Gerrity, T. R., Cotormanes, E., Garrard, C. S., Yeates, D. B., and Lourenco, R. V., The effect of aspirin on lung mucociliary clearance, N. Engl. J. Med., 308, 139, 1983.
177. Pavia, D., Sutton, P. P., Lopez-Vidriero, M. T., Agnew, J. E., and Clarke, S. W., Drug effects on mucociliary function, Eur. J. Respir. Dis., 64, 304, 1983.
178. Leikauf, G., Yeates, D. B., Wales, K. A., Spektor, D., Albert, R. E., and Lippman, M., Effects of sulfuric acid aerosol on respiratory mechanics and mucociliary particle clearance in healthy non-smoking adults, Am. Ind. Hyg. J., 42, 273, 1981.
179. Lippman, M., Schlesinger, R. B., Leikauf., G., Spektor, D., and Albert, R. E., Effects of sulfuric acid aerosols on respiratory tract airways, Inhaled Particles V, The Annals of Occupational Hygiene, Walton, W. H., Critchlow, A., and Coppock, S. M., Eds., Pergamon Press, New York, 1982.
180. Camner, P., Clearance of particles from the human tracheobronchial tree, Clin. Sci., 59, 79, 1980.
181. Kenoyer, J. L., Phalen, R. F., and Davis, J. R., Particle clearance from the respiratory tract as a test of toxicity: Effect of ozone on short and long term clearance, Exp. Lung Res., 2, 111, 1981.
182. Weiss, T., Dorrow, P., and Felix, R., Regional mucociliary removal of inhaled particles in smokers with small airways disease, Respiration, 44, 338, 1983.
183. Foster, W. M., Costa, D. L., and Langenback, E. G., Ozone exposure alters tracheobronchial mucociliary function in humans, J. Appl. Physiol., 63, 996, 1987.
184. Vastag, E., Matthys, H., Zsamboki, G., Kohler, D., and Daileler, G., Mucociliary clearance in smokers, Eur. J. Respir. Dis., 68, 107, 1986.
185. Jarstrand, C., Camner, P., and Philipson, K., Mycoplasma pneumoniae and tracheobronchial clearance, Am. Rev. Respir. Dis., 110, 415, 1974.
186. Camner, P., Jarstrand, C., and Philipson, K., Tracheobronchial clearance in patients with influenza, Am. Rev. Respir. Dis., 108, 131, 1973.
187. Pavia, D., Sutton, P. P., Agnew, J. E., Lopez-Vidriero, M. T., Newman, S. P., and Clarke, S. W., Measurement of bronchial mucociliary clearance, Eur. J. Respir. Dis., 64, 41, 1983.
188. Bateman, J. R. M., Pavia, D., Sheahan, N. F., Agnew, J. E., and Clarke, S. W., Impaired tracheobronchial clearance in patients with mild stable asthma, Thorax, 38, 463, 1983.
189. Pavia, D., Lung mucociliary clearance, Ch. 6, Aerosols and the Lung: Clinical and Experimental Aspects, Clarke, S. W., and Pavia, D., Eds., Butterworths, Boston, MA, 1984.
190. Robinson, M., Everl, S., Tomlinson, C., Daviskas, E., Regnis, J. A., Bailey, D. L., Torzillo, P. J., Ménache, M., and Bye, P. T., Regional mucociliary clearance in patients with cystic fibrosis, J. Aerosol Med., 13, 73, 2000.
191. Goodman, R. M., Yergin, B. M., Landa, J. F., Golinvaux, M. H., and Sackner, M. A., Relationship of smoking history and pulmonary function tests to tracheal mucous velocity in non-smokers, young smokers, ex-smokers, and patients with chronic bronchitis, Am. Rev. Respir. Dis., 117, 205, 1978.
192. Puchelle, E., Sahm, J. M., and Bertrand, A., Influence of age on bronchial mucociliary transport, Scand. J. Respir. Dis., 60, 307, 1979.
193. Vastag, E., Matthys, H., Kohler, D., Gronbeck, L., and Daileler, G., Mucociliary clearance and airway obstruction in smokers, ex-smokers and normal subjects who never smoked, Eur. J. Respir. Dis., 139, 93, 1985.
194. Incalzi, R. A., Maini, C. L., Fuso, L., Giordano, A., Carbonin, P. U., and Galli, G., Effects of aging on mucociliary clearance, Compr. Gerontol. A, 3, 65, 1989.
195. Ho, J. C., Chan, K. N., Hu, W. H., Lam, W. K., Zheng, L., Tipoe, G. L., Sun, J., Leung, R., and Tsang, K. W., The effect of aging on nasal mucociliary clearance, beat, frequency, and ultrastructure of respiratory cilia, Am. J. Respir. Crit. Care Med., 163, 983, 2001.
196. Wolff, R. K., Dolovich, M. B., Obminsky, G., and Newhouse, M. T., Effects of exercise and eucapnic hyperventilation on bronchial clearance in man, J. Appl. Physiol., 43, 46, 1977.
197. Salzano, F. A., Manola, M., Tricarico, D., Precone, D., and Motta, G., Mucociliary clearance after aerobic exertion in athletes, Acta Otorhinolaryngol. Ital., 20, 171, 2000.
198. Adamson, I. Y. and Bowden, D. H., Dose response of the pulmonary macrophagic system to various particulates and its relationship to transepithelial passage of free particles, Exp. Lung Res., 2, 165, 1981.
199. Timbrell, V., Deposition and retention of fibres in the human lung, Ann. Occup. Hyg., 26, 347, 1982.
200. Coin, P. G., Stevens, J. B., McJilton, C. M., Role of fiber length in the pulmonary clearance of amosite asbestos, Am. Rev. Respir. Dis., 141, A521, 1990.
201. Coin, P. G., Roggli, V. L., and Brody, A. R., Persistence of long, thin chrysotile asbestos fibers in the lungs of rats, Environ. Health Perspect., 102, 197, 1994.
202. Donaldson, K. and Tran, C. L., Inflammation caused by particles and fibers, Inhal. Toxicol., 14, 5, 2002.
203. Oberdörster, G., Toxicokinetics and effects of fibrous and nonfibrous particles, Inhal. Toxicol., 14, 29, 2002.
204. Witschi, H. R. and Last, J. A., Toxic responses of the respiratory system, Ch. 15, Caserett and Doul’s Toxicology, The Basic Science of Poisons, 6th edn., Klaasen, C. D., Ed., McGraw-Hill, New York, 2001.
205. Hocking, W. G. and Golde, D. W., The pulmonary alveolar macrophage, N. Engl. J. Med., 301, 580, 1979.
206. Holt, P. G. and Keast, D., Environmentally induced changes in immunologic function. Acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals, Bacteriol. Rev., 41, 205, 1977.
207. Thomas, W. R., Holt, P. G., and Keast, D., Cigarette smoke and phagocyte function: Effect of chronic exposure in vivo and acute exposure in vitro, Infect. Immun., 20, 468, 1978.
208. Oberdörster, G., Lung particle overload: Implication for occupational exposures to particles, Regul. Toxicol. Pharm., 27, 123, 1995.
209. Churg, A., The uptake of mineral particles by pulmonary epithelial cells, Am. J. Respir. Crit. Care Med., 154, 1124-1140, 1996.
210. Churg, A., Wright, J. L., and Stevens, B., Exogenous mineral particles in the human bronchial mucosa and lung parenchyma. I. Nonsmokers in the general population, Exp. Lung Res., 16, 159, 1990.
211. Dumortier, P., De Vuyst, P., and Yernault, J. C., Comparative analysis of inhaled particle contained in human bronchoalveolar fluids, lung parenchyma and lymph nodes, Environ. Health Perspect., 102, 257, 1994.
212. Geiser, M., Morphological aspects of particle uptake by lung phagocytes, Microsc. Res., 57, 512, 2002.
213. Morrow, P. E., Possible mechanisms to explain dust overloading of the lungs, Fundam. Appl. Toxicol., 10, 369, 1988.
214. Ferin, J., Oberdörster, G., and Penney, D. P., Pulmonary retention of ultrafine and fine particles in rats, Am. J. Respir. Cell Mol. Biol., 6, 535, 1992.
215. Ferin, J., Oberdörster, G., Soderhold, S. C., and Gelein, R., The rate of dose delivery affects pulmonary interstitialization of particles in rats, Ann. Occup. Hyg., 38, 289, 1994.
216. Oberdörster, G., Finkelstein, J. N., Johnston, C., Gelein, R., Cox, C., Baggs, R., and Elder, A. C., Acute pulmonary effects of ultrafine particles in rats and mice, Res. Rep. Health Eff. Inst., 96, 5, 2000.
217. Oberdörster, G., Ferin, J., and Lehnert, B. E., Correlation between particle size, in vivo, particle persistence and lung injury, Environ. Health Perspect., 102, 173, 1994.
218. Sosnowski, T. R., Gradón, L., and Podgórski, A., Influence of insoluble aerosol depositions on the surface activity of the pulmonary surfactant: A possible mechanism of alveolar clearance retardation? Aerosol Sci. Technol., 32, 52, 2000.
219. Gerrity, T. R., Garrard, C. S., and Yeates, D. B., A mathematical model of particle retention in the air-spaces of the human lung, Br. J. Ind. Med., 40, 121, 1983.
220. Sanchis, J., Dolovich, M., Chalmers, R., and Newhouse, M., Quantitation of regional aerosol clearance in the normal human lung, J. Appl. Physiol., 33, 757, 1972.
221. Hofmann, W., Ménache, M. G., and Martonen, T. B., Age-dependent lung dosimetry of radon progeny, Extrapolation of Dosimetric Relationships for Inhaled Particles and Gases, Crapo, J. D., Smolko, E. D., Miller, F. J., Graham, J. A., and Hayes, A. W., Eds., Academic Press, San Diego, CA, 1989.
222. Martonen, T. B. and Hofmann, W., Dosimetry of localised accumulations of cigarette smoke and radon progeny at bifurcations, Radiat. Prot. Dosim., 38, 81, 1991.
223. Martonen, T. B., Fleming, J., Schroeter, J., Conway, J., and Hwang, D., In silico modeling of asthma, Adv. Drug Deliv. Rev., 55, 829, 2003.
224. Davis, P. B., Drumm, M., and Knostan, M. W., Cystic fibrosis, Am. J. Respir. Crit. Care Med., 154, 1229, 1996.
225. Brown, J. S., Regional ventilation and particle deposition in the healthy and obstructed lung, UMI Dissertation Services, Ann Arbor, MI, 2000.
226. Kim, C. S. and Kang, T. C., Comparative measurement of lung deposition of inhaled fine particles in normal subjects and patients with obstructive airway disease, Am. J. Respir. Crit. Care Med., 155, 3, 1997.
227. Anderson, P. J., Blanchard, J. D., Brain, J. D., Feldman, H. D., McNamara, J. J., and Heyder, J. Effect of cystic fibrosis on inhaled aerosol boluses. Am. Rev. Respir. Dis., 140, 1317, 1989.
228. Anderson, P. J., Wilson, J. D., and Hiller, F. C., Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease, Chest, 97, 115, 1990.
229. Love, R. G. and Muir, D. C. F., Aerosol deposition and airway obstruction, Am. Rev. Respir. Dis., 114, 891, 1976.
230. Siekmeier, R., Schiller-Scotland, C. H. F., Gebhart, J., and Kronenberger, H., Pharmacon-induced airway obstruction in healthy subjects: Dose dependent changes of inspired aerosol boluses, J. Aerosol Sci., 21, S423, 1990.
231. Anderson, P. J., Gann, L. P., Walls, R. C., Tennal, K. B., and Hiller, F. C., Utility of aerosol bolus behavior as a diagnostic index of asthma during bronchoprovocation, Am. J. Respir. Crit. Care Med., 149, A1047, 1994.
232. Brown, J. S., Zeman, K. L., and Bennett, W. D., Regional deposition of coarse particles and ventilation distribution in healthy subjects and patients with cystic fibrosis, J. Aerosol Med., 14, 443, 2001.
233. Ramana, L., Tashkin, D. P., Taplin, G. V., Elam, D., Detels, R., Coulson, A., and Rokaw, S. N., Lung imaging in chronic obstructive pulmonary disease, Chest, 68, 634, 1975.
234. Taplin, G. V., Tashkin, D. P., Chopri, S. K., Anselmi, O. E., Elam, D., Calvarese, B., Coulson, A., Detels, R., and Rokaw, S. N., Early detection of chronic obstructive pulmonary disease using radionuclide lung imaging procedures, Chest, 71, 567, 1977.
235. Ito, H., Ishii, Y., Maeda, H., Todo, G., Torizuka, K., and Smaldone, G. C., Clinical observations of aerosol deposition in patients with airway obstruction, Chest, 80, 837, 1981.
236. Segal, R. A., Martonen, T. B., Kim, C. S., and Shearer, M., Computer simulations of particle deposition in the lungs of chronic obstructive pulmonary disease patients, Inhal. Toxicol., 14, 705, 2002.
237. Martonen, T. B., Katz, I., Hwang, D., and Yang, Y. Biomedical application of the supercomputer: Targeted delivery of inhaled pharmaceuticals in diseased lungs, Computer Simulations in Biomedicine, Power, H., Hart, R. T., Eds., Computational Mechanics Publications, Boston, MA, 1995.
238. Martonen, T. B., Katz, I., and Cress, W., Aerosol deposition as a function of airway disease: Cystic fibrosis, Pharm. Res., 12, 96, 1995.
239. Martonen, T. B., Hwang, D., Katz, I., and Yang, Y., Cystic fibrosis: Treatment with a supercomputer drug delivery model, Adv. Eng. Software, 28, 359, 1997.
240. Environmental Protection Agency, 40 CFR Part 50, National ambient air quality standards for particulate matter (AD-FRL-5725-2, RIN 2060-AE66), Federal Register, 62, 38651, 1997.
241. Ménache, M. G. and Graham, R. C., Conducting airway geometry as a function of age, Ann. Occup. Hyg., 41, 531, 1997.
242. Hofmann, W., Martonen, T. B., and Graham, R. C., Predicted deposition of nonhygroscopic aerosols in the human lung as a function of subject age, J. Aerosol Med., 2, 49, 1989.
243. Martonen, T. B., Graham, R. C., and Hofmann, W., Human subject age and activity level: Factors addressed in biomathematical deposition program for extrapolation modeling, Health Phys., 57, 49, 1989.
244. Warren, D. W., Harifield, W. M., and Dalston, E. T., Effect of age on nasal cross-sectional area and respiratory mode in children, Laryngoscope, 100, 89, 1990.
245. Bennett, W. D., Zeman, K. L., Kang, C. W., and Schechter, M. S., Extrathoracic deposition of inhaled, coarse particles in children vs. adults, Ann. Occup. Hyg., 41, 497, 1997.
246. Isaacs, K. K. and Martonen, T. B., Particle deposition in children’s lungs: Theory and experiment, J. Aerosol Med., 18, 337, 2005.
247. Harvey, R. P. and Hamby, D. M., Age-specific uncertainty in particulate deposition for 1 micron AMAD particles using ICRP 66 lung model, Health Phys., 82, 807, 2002.
248. Musante C. J. and Martonen, T. B., Computer simulations of particle deposition in the developing human lung, J. Air Waste Manage. Assoc., 50, 1426, 2000.
249. Sweeney, T. D. and Brain, J. D., Pulmonary deposition: Determinants and measurement techniques, Toxicol. Pathol., 19, 384, 1991.
250. Kim, C. S., Methods of calculating lung delivery and deposition of aerosol particles, Respir. Care, 45, 695, 2000.
251. Schlesinger, R. B. and Lippmann, M., Particle deposition in casts of the human upper tracheobronchial tree, Am. Ind. Hyg. Assoc. J., 33, 237, 1972.
252. Cohen, B. S., Particle deposition in human and canine tracheobronchial casts: A determinant of radon dose to the critical cells of the respiratory tract, Health Phys., 70, 695, 1996.
253. Phalen, R. F., Oldham, M. J., Beaucage, C. B., Crocker, T. T., and Mortensen, J. D., Postnatal enlargement of human tracheobronchial airways and implications for particle deposition, Anatom. Rec., 212, 368, 1986.
254. Gerde, P., Cheng, Y. S., and Medinsky, M. A., In vivo deposition of ultrafine aerosols in the nasal airway of the rat, Fund. Appl. Toxicol., 16, 330, 1991.
255. Kelly, J. T., Kimbell, J. S., and Asgharian, B., Deposition of fine and coarse aerosols in a rat nasal mold, Inhal. Toxicol., 13, 577, 2001.
256. Martonen, T. B., Measurements of particle dose distribution in a model of a human larynx and tracheobronchial tree, J. Aerosol Sci., 14, 11, 1983.
257. Martonen, T. B. and Lowe, J., Assessment of aerosol deposition patterns in human respiratory tract casts, Aerosols in the Mining and Industrial Work Environments, Marple, V. A. and Liu, B. Y. H., Eds., Ann Arbor Science, Ann Arbor, MI, 1983.
258. Schlesinger, R. B., Bohning, D. B., Chan, T. L., and Lippmann, M., Particle deposition in a hollow cast of the human tracheobronchial tree, J. Aerosol Sci., 8, 429, 1977.
259. Minocchieri, S., Burren, J. M., Bachmann, M. A., Stern, G., Wildhaber, J., Buob, S., Schindel, R., Kraemer, R., Frey, U. P., and Nelle, M., Development of the premature infant nose throat-model (PrINT-Model)-An upper airway replica of a premature neonate for the study of aerosol delivery, Pediatr. Res., 64, 141, 2008.
260. Janssens, H. M., de Jongste, J. C., Fokkens, W. J., Robben, S. G., Wouters, K., and Tiddens, H. A., The Sophia Anatomical Infant Nose-Throat (Saint) model: A valuable tool to study aerosol deposition in infants, J. Aerosol Med., 14, 433, 2001.
261. Giesel, F. L., Mehndiratta, A., von Tengg-Kobligk, H., Schaeffer, A., Teh, K., Hoffman, E. A., Kauczor, H. U., van Beek, E. J., and Wild, J. M., Rapid prototyping raw models on the basis of high resolution computed tomography lung data for respiratory flow dynamics, Acad. Radiol., 16, 495, 2009.
262. Davies, C. N., Heyder, J., and Subba Ramu, M. C., Breathing of half-micron aerosols I. Experimental, J. Appl. Physiol., 32, 591, 1972.
263. Heyder, J., Gebhardt, J., Heiger, G., Roth, C., and Stahlhofen, W., Experimental studies of the total deposition of aerosol particles in the human respiratory tract, J. Aerosol Sci., 4, 191, 1973.
264. Rosati, J. A., Brown, J. S., Peters, T. M., Leith, D., and Kim, C. S., A polydisperse aerosol inhalation system designed for human studies, J. Aerosol Sci., 33, 1433, 2002.
265. Rosati, J. A., Leith, D., and Kim, C. S., Monodisperse and polydisperse aerosol deposition in a packed bed, Aerosol Sci. Technol., 37, 528, 2000.
266. Laube, B. L., In vivo measurements of aerosol dose and distribution: Clinical relevance, J. Aerosol Med., 9, S77, 1996.
267. Martonen, T. B., Yang, Y., and Dolovich, M., Definition of airway composition within gamma camera images, J. Thorac. Imaging, 9, 188, 1994.
268. Martonen, T. B., Yang, Y., Dolovich, M., and Guan, X., Computer simulations of lung morphologies within planar gamma camera images, Nucl. Med. Commun., 18, 861, 1997.
269. Tossici-Bolt, L., Fleming, J. S., Conway, J. H., and Martonen, T. B., An analytical technique to recover the third dimension in planar imaging of inhaled aerosols-2 estimation of the deposition per airway generation, J. Aerosol Med., 20, 127, 2007.
270. Tossici-Bolt, L., Fleming, J. S., Conway, J. H., and Martonen, T. B., Analytical technique to recover the third dimension in planar imaging of inhaled aerosols: (1) impact on spatial quantification, J. Aerosol Med., 19, 565, 2006.
271. Fleming, J. S., Halson, P., Conway, J., Moore, E., Nassim, M. A., Hashish, A. H., Bailey, A. G., and Holgate, S. T., Three-dimensional description of pulmonary deposition of inhaled aerosol using data from multimodality imaging, J. Nucl. Med., 37, 873, 1996.
272. Fleming, J. S., Sauret, V., Conway, J. H., Holgate, S. T., Bailey, A. G., and Martonen, T. B., Evaluation of the accuracy and precision of lung aerosol deposition measurements from single-photon emission computed tomography using simulation, J. Aerosol Med., 13, 187, 2000.
273. Finlay, W. H., Stapleton, K. W., Chan, H. K., Zuberbuhler, P., and Gonda, I., Regional deposition of inhaled hygroscopic aerosols: In vivo SPECT compared with mathematical modeling, J. Appl. Physiol., 81, 374, 1996.
274. Lee, Z., Berridge, M. S., Finlay, W. H., and Heald, D. L., Mapping PET-measured triamcinolone acetonide (TAA) aerosol distribution into deposition by airway generation, Int. J. Pharm., 199, 7, 2000.
275. Dolovich, M. B., Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung, Respir. Care, 45, 597, 2000.
276. Dolovich, M. B., Measuring total and regional lung deposition using inhaled radiotracers, J. Aerosol Med., 14, S53, 2001.
277. Fleming, J. S., Nassim, M., Hashish, A. H., Bailey, A. G., Conway, J., Holgate, S., Halson, P., and Moore, E., Description of pulmonary deposition of radiolabeled aerosol by airway generation using a conceptual three dimensional model of lung morphology, J. Aerosol Med., 8, 341, 1995.
278. Fleming, J. S., Hashish, A. H., Conway, J., Hartley-Davies, R., Nassim, M. A., Guy, M. J., Coupe, J., and Holgate, S. T., A technique for simulating radionuclide images from the aerosol deposition pattern in the airway tree, J. Aerosol Med., 10, 199, 1997.
279. Martonen, T. B., Hwang, D., Guan, X., and Fleming, J. S., Supercomputer description of human lung morphology for imaging analysis, J. Nucl. Med., 39, 745, 1998.
280. Schroeter, J. D., Fleming, J. S., Hwang, D., and Martonen, T. B., A computer model of lung morphology to analyze SPECT images, Comput. Med. Imaging Graph., 26, 237, 2002.
281. Martonen, T. B., Deposition patterns of cigarette smoke in human airways, Am. Ind. Hyg. Assoc. J., 53, 6, 1992.
282. Hofmann, W. and Koblinger, L., Monte Carlo modeling of aerosol deposition in human lungs: Part III: Comparison with experimental data, J. Aerosol Sci., 23, 51, 1992.
283. Heyder, J., Gebhardt, J., Rudolf, G., Schiller, C. F., and Stahlhofen, W., Deposition of particles in the human respiratory tract in the size range 0.005-15 µm, J. Aerosol Sci., 17, 811, 1986.
284. Segal, R. A., Martonen, T. B., and Kim, C. S., Comparison of computer simulations of total lung deposition to human subject data in healthy test subjects, J. Air Waste Manage. Assoc., 50, 1262, 2000.
285. Swift, D. L. and Proctor, D. F., Access of air to the respiratory tract, Respiratory Defense Mechanisms, Brain, J. D., Proctor, D. F., and Reid, L., Eds., Marcel Dekker, New York, 1977.
286. Heyder, J. and Rudolf, G., Deposition of aerosol particles in the human nose, Inhaled Part., 4, 107, 1975.
287. Foord, N., Black, A., and Walsh, M., Regional deposition of 2.5-7.5 µm diameter inhaled particles in the healthy male non-smoker, J. Aerosol Sci., 9, 343, 1978.
288. Cheng, K. H., Cheng, Y. S., Yeh, H. C., and Swift, D. L., Measurements of airway dimensions and calculation of mass transfer characteristics of the human oral passage, J. Biomech. Eng., 119, 476, 1997.
289. Swift, D. L. and Proctor, D. F., A dosimetric model for particles in the respiratory tract above the trachea, Ann. Occup. Hyg., 32, 1035, 1982.
290. Martonen, T. B. and Zhang, Z., Comments on recent data for particle deposition in human nasal passages, J. Aerosol Sci., 23, 667, 1992.
291. Kelly, J. T., Asgharian, B., Kimbell, J. S., and Wong, B. A., Particle deposition in human nasal airway replicas manufactured by different methods. Part I: Inertial regime particles, Aerosol Sci. Technol., 38, 1063, 2004.
292. Kelly, J. T., Asgharian, B., Kimbell, J. S., and Wong, B. A., Particle deposition in human nasal airway replicas manufactured by different methods. Part II: Ultrafine particles, Aerosol Sci. Technol., 38, 1072, 2004.
293. Cheng, Y. S., Zhou, Y., and Chen, B. T., Particle deposition in a cast of human oral airways, Aerosol Sci. Technol., 31, 286, 1999.
294. Kim, C. S. and Fisher, D. M., Deposition characteristics of aerosol particles in sequentially bifurcating airway models, Aerosol Sci. Technol., 31, 198, 1999.
295. Farkas, A. and Balashazy, I., Quantification of particle deposition in asymmetrical tracheobronchial model geometry, Comput. Biol. Med., 38, 508, 2008.
296. Schlesinger, R. B., Gurman, J. L., and Lippmann, M., Particle deposition within bronchial airways-Comparisons using constant and cyclic inspiratory flows, Ann. Occup. Hyg., 26, 47, 1982.
297. U.S. EPA, Total Risk Integrated Methodology (TRIM) Air Pollutants Exposure Model Documentation (TRIM.Expo/APEX, Version 4.3). Vol. 1: Users Guide. Report no. EPA-452/B-08-001a. Office of Air Quality Planning and Standards, Research Triangle Park, NC. Available at: http://www.epa.gov/ttn/fera/human_apex.html, 2008.
298. U.S. EPA, Total Risk Integrated Methodology (TRIM) Air Pollutants Exposure Model Documentation (TRIM.Expo/APEX, Version 4.3). Vol. 2: Technical Support Document. Report no. EPA-452/B-08-001b. Office of Air Quality Planning and Standards, Research Triangle Park, NC. Available at: http://www.epa.gov/ttn/fera/human_apex.html, 2008b.
299. Burke, J. M., Zufall, M. J., and Ozkaynak, H. A population exposure model for particulate matter: Case study results for PM2.5 in Philadelphia, PA, J. Expo. Anal. Environ. Epidemol., 11, 470, 2001.
300. U.S. EPA, Exposure model for individuals, 2011, Available at: http://www.epa.gov/heasd/products/emi/emi.html
301. National Institute for Public Health and the Environment (RIVM). Multiple path particle dosimetry model (MPPD v 1.0): A model for human and rat airway particle dosimetry. Bilthoven, the Netherlands. RIVA Report 650010030. Model available online at http://www.ara.com/products/mppd.htm., 2002.
302. Bondesson, E., Bengtsson, T., Borgstrom, L., Nilsson, L. E., Norrgren, K., Olsson, B., Svensson, M., and Wollmer, P., Dose delivery late in the breath can increase dry powder aerosol penetration into the lungs, J. Aerosol Med., 18, 23, 2005.
303. Kleinstreuer, C., Shi, H., and Zhang, Z., Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology, J. Aerosol. Med., 20, 294, 2007.
304. Zhang, Y., Gilbertson, K., and Finlay, W. H., In vivo-in vitro comparison of deposition in three mouth-throat models with Qvar and Turbuhaler inhalers, J. Aerosol. Med., 20, 227, 2007.
305. Coates, M. S., Fletcher, D. F., Chan, H. K., and Raper, J. A., Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: Grid structure and mouthpiece length, J. Pharm. Sci., 93, 2863, 2004.
306. Coates, M. S., Chan, H. K., Fletcher, D. F., and Chiou, H., Influence of mouthpiece geometry on the aerosol delivery performance of a dry powder inhaler, Pharm. Res., 24, 1450, 2007.
307. Longest, P. W., Hindle, M., Das Choudhuri, S., and Xi, J. X., Comparison of ambient and spray aerosol deposition in a standard induction port and more realistic mouth-throat geometry, J. Aerosol Sci., 39, 572, 2008.
308. Longest, P. and Hindle, M., Evaluation of the Respimat soft mist inhaler using a concurrent CFD and in vitro approach, J. Aerosol Med. Pulm. Drug Deliv., 22, 99, 2009.
309. Kimbell, J. S., Segal, R. A., Asgharian, B., Wong, B. A., Schroeter, J. D., Southall, J. P., Dickens, C. J., Brace, G., and Miller, F. J., Characterization of deposition from nasal spray devices using a computational fluid dynamics model of the human nasal passages, J. Aerosol Med., 20, 59, 2007.
310. Longest, P. W. and Hindle, M., CFD simulations of enhanced condensational growth (ECG) applied to respiratory drug delivery with comparisons to in vitro data, J. Aerosol Sci., 41, 805, 2010.
311. Hindle, M. and Longest, P. W., Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial model, Pharm. Res., 27, 1800, 2010.